metabolic profiling of Parkinson's disease and mild cognitive impairment

Background: Early diagnosis of Parkinson's disease and mild cognitive impairment is important to enable prompt treatment and improve patient welfare, yet no standard diagnostic test is available. Metabolomics is a powerful tool used to elucidate disease mechanisms and identify potential biomark...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mov Disord
Egile Nagusiak: Burté, Florence, Houghton, David, Lowes, Hannah, Pyle, Angela, Nesbitt, Sarah, Yarnall, Alison, Yu‐Wai‐Man, Patrick, Burn, David J., Santibanez‐Koref, Mauro, Hudson, Gavin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485028/
https://ncbi.nlm.nih.gov/pubmed/28394042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26992
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak